Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

BR802b

Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including TNM and pathology grade, 47cases/80cores, replacing BR802
Price: $215.00 Add to Cart
H&E (BR802bs*): $215.00 Add to Cart

Microarray Panel:Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue microarray, containing 35 cases of breast invasive ductal carcinoma, 2 each of breast mucinous carcinoma and medullary carcinoma, 1 breast apocrine carcinoma plus 5 adjacent normal breast tissue and 2 normal breast tissue, duplicate cores per case
Cores:80
Cases:47
Layout:10 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678910 
A Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
B Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
C Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
D Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
E Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
F Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
G Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
H Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre Marked point
Legend: Bre - Breast

- Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage IIIa), - Malignant tumor (stage IIIb), - Malignant tumor (stage IIa), - Malignant tumor (stage IIb), - NAT, - Normal tissue

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 39 Breast Invasive ductal carcinoma 1 IIa T2N0M0 Malignant
A2 2 F 44 Breast Invasive ductal carcinoma 1 IIIa T2N2M0 Malignant
A3 3 F 40 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
A4 4 F 40 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
A5 5 F 52 Breast Invasive ductal carcinoma (sparse) – IIa T2N0M0 Malignant
A6 6 F 50 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
A7 7 F 44 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
A8 8 F 46 Breast Invasive ductal carcinoma 2 IIIa T3N2M0 Malignant
A9 9 F 51 Breast Invasive ductal carcinoma (sparse) – I T1cN0M0 Malignant
A10 10 F 40 Breast Invasive ductal carcinoma 3 IIa T2N0M0 Malignant
B1 11 F 39 Breast Invasive ductal carcinoma 3 IIa T2N0M0 Malignant
B2 12 F 36 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
B3 13 F 43 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
B4 14 F 48 Breast Invasive ductal carcinoma 2 IIIb T4N0M0 Malignant
B5 15 F 45 Breast Invasive ductal carcinoma 2 I T1cN0M0 Malignant
B6 16 F 50 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
B7 17 F 38 Breast Invasive ductal carcinoma 1 IIa T2N0M0 Malignant
B8 18 F 50 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
B9 19 F 52 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
B10 20 F 44 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
C1 21 F 45 Breast Invasive ductal carcinoma 1 IIb T2N1M0 Malignant
C2 22 F 48 Breast Invasive ductal carcinoma 3 IIa T2N0M0 Malignant
C3 23 F 60 Breast Invasive ductal carcinoma 2 IIIb T4N2M0 Malignant
C4 24 F 36 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
C5 25 F 39 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
C6 26 F 53 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
C7 27 F 48 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
C8 28 F 40 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
C9 29 F 38 Breast Invasive ductal carcinoma 2 IIIb T4N0M0 Malignant
C10 30 F 48 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
D1 31 F 39 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
D2 32 F 40 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
D3 33 F 64 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
D4 34 F 48 Breast Invasive ductal carcinoma 2 IIb T3N0M0 Malignant
D5 35 F 58 Breast Mucinous carcinoma – IIIb T4N1M0 Malignant
D6 36 F 40 Breast Mucinous carcinoma – IIb T3N0M0 Malignant
D7 37 F 48 Breast Invasive ductal carcinoma 3 IIIb T4N0M0 Malignant
D8 38 F 48 Breast Medullary carcinoma – I T1N0M0 Malignant
D9 39 F 34 Breast Medullary carcinoma – IIa T2N0M0 Malignant
D10 40 F 54 Breast Apocrine carcinoma – IIa T2N0M0 Malignant
E1 41 F 39 Breast Cancer adjacent normal breast tissue of No.01 (fibrofatty tissue and blood vessel) – – – NAT
E2 42 F 44 Breast Cancer adjacent normal breast tissue of No.02 – – – NAT
E3 43 F 40 Breast Cancer adjacent normal breast tissue of No.03 (fibrofatty tissue and blood vessel) – – – NAT
E4 44 F 40 Breast Cancer adjacent normal breast tissue of No.04 (fibrofatty tissue and blood vessel) – – – NAT
E5 45 F 52 Breast Cancer adjacent normal breast tissue of No.05 (invasive ductal carcinoma) 1 – – NAT
E6 46 F 50 Breast Cancer adjacent normal breast tissue of No.06 – – – NAT
E7 47 F 44 Breast Cancer adjacent normal breast tissue of No.07 – – – NAT
E8 48 F 46 Breast Cancer adjacent normal breast tissue of No.08 – – – NAT
E9 49 F 51 Breast Cancer adjacent normal breast tissue of No.09 – – – NAT
E10 50 F 40 Breast Cancer adjacent normal breast tissue of No.10 – – – NAT
F1 51 F 39 Breast Cancer adjacent normal breast tissue of No.11 – – – NAT
F2 52 F 36 Breast Cancer adjacent normal breast tissue of No.12 – – – NAT
F3 53 F 43 Breast Cancer adjacent normal breast tissue of No.13 – – – NAT
F4 54 F 48 Breast Cancer adjacent normal breast tissue of No.14 – – – NAT
F5 55 F 45 Breast Cancer adjacent normal breast tissue with tumor embolus of No.15 – – – NAT
F6 56 F 50 Breast Cancer adjacent normal breast tissue of No.16 – – – NAT
F7 57 F 38 Breast Cancer adjacent normal breast tissue of No.17 (fibrofatty tissue and blood vessel) – – – NAT
F8 58 F 50 Breast Cancer adjacent normal breast tissue of No.18 (fibrofatty tissue and blood vessel) – – – NAT
F9 59 F 52 Breast Cancer adjacent normal breast tissue of No.19 – – – NAT
F10 60 F 44 Breast Cancer adjacent normal breast tissue of No.20 – – – NAT
G1 61 F 45 Breast Cancer adjacent normal breast tissue of No.21 – – – NAT
G2 62 F 48 Breast Cancer adjacent normal breast tissue of No.22 – – – NAT
G3 63 F 60 Breast Cancer adjacent normal breast tissue of No.23 (fibrofatty tissue and blood vessel) – – – NAT
G4 64 F 38 Breast Cancer adjacent normal breast tissue – – – NAT
G5 65 F 18 Breast Normal breast tissue – – – Normal
G6 66 F 50 Breast Normal breast tissue – – – Normal
G7 67 F 48 Breast Cancer adjacent normal breast tissue of No.27 – – – NAT
G8 68 F 40 Breast Cancer adjacent normal breast tissue of No.28 – – – NAT
G9 69 F 38 Breast Cancer adjacent normal breast tissue of No.29 – – – NAT
G10 70 F 48 Breast Cancer adjacent normal breast tissue of No.30 – – – NAT
H1 71 F 39 Breast Cancer adjacent normal breast tissue of No.31 – – – NAT
H2 72 F 40 Breast Cancer adjacent normal breast tissue (fibrous tissue and blood vessel) – – – NAT
H3 73 F 64 Breast Cancer adjacent normal breast tissue of No.33 (fibrous tissue and blood vessel) – – – NAT
H4 74 F 48 Breast Cancer adjacent normal breast tissue of No.34 – – – NAT
H5 75 F 58 Breast Cancer adjacent normal breast tissue of No.35 – – – NAT
H6 76 F 40 Breast Cancer adjacent normal breast tissue of No.36(fibrofatty tissue and blood vessel) – – – NAT
H7 77 F 48 Breast Cancer adjacent normal breast tissue (sparse) – – – NAT
H8 78 F 39 Breast Cancer adjacent normal breast tissue – – – NAT
H9 79 F 49 Breast Cancer adjacent normal breast tissue – – – NAT
H10 80 F 39 Breast Cancer adjacent normal breast tissue of No.25 – – – NAT
– – F 55 liver Hepatocellular liver cancer (tissue marker) 3 T3N0M0 Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal